Exosomal miRNA-146a is downregulated in clear cell renal cell carcinoma patients with severe immune-related adverse events
Here we report the results of the pilot project of exosomal miRNA expression levels in clear cell renal cell carcinoma (ccRCC) patients with different clinical response to ICIs (nivolumab) and treatment related toxicity. Immune-related adverse events (irAEs) are a major cause of immune checkpoint in...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co.
2022
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |